DR. ROBERT T O'DONNELL, M.D., PH.D.
Osteopathic Medicine at X St, Sacramento, CA
License number
California G063398
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
4501 X St, Sacramento, CA 95817
Phone
(916) 734-3772
(916) 734-7946 (Fax)
(916) 734-7946 (Fax)
Professional information
Robert Thomas O'Donnell, Sacramento CA
Specialties:
Internal Medicine, Hematology & Oncology, Medical Oncology
Work:
Uc Davis Cancer Center
4501 X St, Sacramento, CA 95817
4501 X St, Sacramento, CA 95817
Education:
Loyola University Chicago (1987)
Dr. Robert T O'donnell, Sacramento CA - MD (Doctor of Medicine)
Address:
UC Davis Cancer Center
4501 X St STE 2, Sacramento 95817
(916) 734-5959 (Phone)
4501 X St STE 2, Sacramento 95817
(916) 734-5959 (Phone)
Hospitals:
UC Davis Cancer Center
4501 X St STE 2, Sacramento 95817
4501 X St STE 2, Sacramento 95817
Education:
Medical Schools
Loyola University Of Chicago/Stritch School Of Medicine
Graduated: 1987
Loyola University Of Chicago/Stritch School Of Medicine
Graduated: 1987
Robert T O'Donnell, Sacramento CA
Specialties:
Oncologist
Address:
4501 X St, Sacramento, CA 95817
Antigenic Epitopes With Lym-1 Reactivity And Uses Thereof
US Patent:
2001001, Sep 6, 2001
Filed:
Apr 10, 2001
Appl. No.:
09/832510
Inventors:
Larry Rose - Carmichael CA, US
Claude Meares - Davis CA, US
Robert O'Donnell - Sacramento CA, US
Claude Meares - Davis CA, US
Robert O'Donnell - Sacramento CA, US
International Classification:
C12Q001/68, G01N033/574, A61K039/00
US Classification:
435/006000, 435/007230, 424/184100
Abstract:
This invention provides novel peptide epitopes recognized by the non-Hodgkin's B cell lymphoma reactive Lym-1 antibody. These novel peptide epitopes are capable of generating antibodies directed against Lym-1 peptide epitope expressing B-NHL cells. This invention is also directed to the treatment of B-NHL.
Antigenic Epitopes With Lym-1 Reactivity And Uses Thereof
US Patent:
6217871, Apr 17, 2001
Filed:
Oct 28, 1998
Appl. No.:
9/181896
Inventors:
Larry M. Rose - Carmichael CA
Claude F. Meares - Davis CA
Robert T. O'Donnell - Sacramento CA
Claude F. Meares - Davis CA
Robert T. O'Donnell - Sacramento CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3900
US Classification:
4241841
Abstract:
This invention provides novel peptide epitopes recognized by the non-Hodgkin's B cell lymphoma reactive Lym-1 antibody. These novel peptide epitopes are capable of generating antibodies directed against Lym-1 peptide epitope expressing B-NHL cells. This invention is also directed to the treatment of B-NHL.
Fermented Wheat Germ Proteins (Fwgp) For The Treatment Of Cancer
US Patent:
2012012, May 17, 2012
Filed:
May 20, 2010
Appl. No.:
13/320898
Inventors:
Joseph Tuscano - Folsom CA, US
Derick Lau - Roseville CA, US
Robert O'Donnell - Sacramento CA, US
Yunpeng Ma - Sichuan, CN
Derick Lau - Roseville CA, US
Robert O'Donnell - Sacramento CA, US
Yunpeng Ma - Sichuan, CN
Assignee:
UNITED STATES GOVERNMENT AS THE REPRESENTED BY THE - WASHINGTON DC
REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 38/02, A61K 38/48, A61K 39/395, A61K 38/52, A61P 35/00, C12N 5/09, A61K 38/44
US Classification:
4241741, 514 193, 435375, 514 194, 424 9463, 424 944, 424 945
Abstract:
The present invention provides compositions comprising the component of fermented wheat germ extract (“FWGE”) active in reducing, inhibiting or preventing the proliferation of cancer cells and/or tumors, and methods of making and using such compositions. The active component from FWGE comprises polypeptides having a molecular weight in the range of about 5-100 kiloDaltons (kD), for example, a molecular weight in the range of about 12-50 kD. Exemplary polypeptides from FWGE determined to be active in reducing, inhibiting or preventing the proliferation of cancer cells and/or tumors are listed in Table 1.